Table 3.
Effect Sizes of Improvements from Pre-Treatment to Post-Treatment, 3 Months Follow-up, 6 Months Follow-up, and 12 Months Follow-up
| Post 7 days | 3 mos. - FU | 6 mos. - FU | 12 mos. - FU | |
|---|---|---|---|---|
| WSAS | — | 1.61 | 1.49 | 1.26 |
| GAD-7 | 1.19 | 1.43 | 1.29 | 1.20 |
| PHQ-9 | 1.46 | 1.49 | 1.27 | 1.19 |
| PSWQ | 0.60 | 1.01 | 1.03 | 0.88 |
| CFQ | 0.98 | 1.54 | 1.47 | 0.95 |
| BIS | 0.64 | 0.94 | 0.75 | 0.81 |
| BIPQ | 3.02 | 3.67 | 3.66 | 2.81 |
Note WSAS = Work and social adjustment scale; GAD-7 = General anxiety disorder;
PHQ-9 = Patient health questionnaire; PSWQ = Penn State worry questionnaire;
CFQ = Chalder fatigue Scale; BIPQ = Brief illness perception questionnaire; FU = Follow-up.
Effect sizes computed as Glass’s Δ = 